Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile
Titel:
Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile
Auteur:
Monath, Thomas P. Kortekaas, Jeroen Watts, Douglas M. Christofferson, Rebecca C. Desiree LaBeaud, Angelle Gowen, Brian B Peters, Clarence J. Smith, Darci R. Swanepoel, Robert Morrill, John C. Ksiazek, Thomas G. Pittman, Phillip R Nichol, Stuart T. Bird, Brian H. Bettinger, George